期刊文献+

回顾性分析单核苷酸多态性微阵列分析技术在胎儿先天性心脏病诊断中的应用价值 被引量:2

Retrospective analysis of single nucleotide polymorphism microarray analysis technique in the diagnosis of fetal congenital heart disease
下载PDF
导出
摘要 目的回顾性分析单核苷酸多态性微阵列(SNP array)分析技术在胎儿先天性心脏病(CHD)诊断中的应用价值。方法选取2017年1月至2021年12月因超声心动图提示胎儿CHD就诊于该院遗传咨询门诊的妊娠18~25周孕妇140例为研究对象,入选孕妇均进行染色体核型分析及SNP array分析。结果超声心动图显示,140例CHD胎儿中孤立性心脏畸形、多发性心脏畸形、合并心外畸形分别有66例、34例和40例。染色体核型分析检出染色体异常9例(6.43%),SNP array分析检出染色体异常20例(14.29%);两种检测技术对CHD中微缺失和微重复的总检出率差异有统计学意义(P<0.05)。SNP array分析在未合并心外畸形胎儿中检出染色体异常占8.00%(8/100),在合并心外畸形胎儿中检出染色体异常占30.00%(12/40),差异有统计学意义(P<0.05)。SNP array分析共检出14例染色体拷贝数变异(CNV),其中致病性CNV 3例,临床意义不明确CNV 11例。结论相较于传统染色体核型分析,SNP array分析能提高染色体异常的检出率,胎儿CHD采用染色体核型分析联合SNP array分析更有助于临床医生分析胎儿的产前遗传学病因。 Objective To retrospectively analyze the application value of single nucleotide polymorphism microarray(SNP array)analysis technique in the diagnosis of fetal congenital heart disease(CHD).Methods From January 2017 to December 2021,a total of 140 pregnant women at 18-25 weeks of gestation who were admitted to the genetic counseling clinic of the hospital because of fetal CHD indicated by echocardiography were selected as the research objects.Chromosomal karyotype analysis and SNP array analysis were performed on all pregnant women.Results Echocardiography showed that there were 66 cases of isolated heart malformation,34 cases of multiple heart malformation,and 40 cases of combined extracardiac malformation in 140 CHD fetuses.Chromosomal karyotype analysis detected 9 cases(6.43%)of chromosomal abnormalities,and SNP array analysis detected 20 cases(14.29%)of chromosomal abnormalities.There were significant differences in the total detection rate of microdeletions and microduplications between the two detection techniques in CHD(P<0.05).SNP array analysis showed that chromosomal abnormalities accounted for 8.00%(8/100)in fetuses without extracardiac malformations,and 30.00%(12/40)in fetuses with extracardiac malformations,and the difference wa s statistically significant(P<0.05).A total of 14 cases of chromosomal copy number variation(CNV)were detected by SNP array analysis,including 3 cases of pathogenic CNV and 11 cases of unclear clinical significance CNV.Conclusion Compared with traditional chromosomal karyotype analysis,SNP array analysis can improve the detection rate of chromosomal abnormalities.Chromosomal karyotype analysis combined with SNP array analysis is more helpful for clinicians to analyze the prenatal genetic causes of fetal CHD.
作者 林琴 黄秀琼 毛雅珍 沈玲英 刘欣茹 LIN Qin;HUANG Xiuqiong;MAO Yazhen;SHEN Lingying;LIU Xinru(Department of Clinical Laboratory,Affiliated Fuzhou First Hospital of Fujian Medical University,Fuzhou,Fujian 350000,China;Department of Obstetrics,Affiliated Fuzhou First Hospital of Fujian Medical University,Fuzhou,Fujian 350000,China)
出处 《国际检验医学杂志》 CAS 2022年第23期2891-2895,2901,共6页 International Journal of Laboratory Medicine
基金 福建省福州市市级临床医学中心建设项目(2018080301)。
关键词 先天性心脏病 单核苷酸多态性微阵列分析 染色体拷贝数变异 产前诊断 congenital heart disease single nucleotide polymorphism microarray analysis chromosomal copy number variation prenatal diagnosis
  • 相关文献

参考文献9

二级参考文献61

  • 1Iafrate AJ, Feuk L, Rivera MN, et al. Detection of large- scale variation in the human genome [J]. Nat Genet, 2004, 36(9): 949-951.
  • 2Sebat J, Lakshmi B, Troge J, et al. Large-scale copy number polymorphism in the human genome [J]. Science, 2004, 305(5683): 525-528.
  • 3Fan YS, Ouyang X, Peng J, et al. Frequent detection of parental consanguinity in children with developmental disorders by a combined CGH and SNP microarray [J]. Mol Cytogenet, 2013, 6(1): 38.
  • 4Kaminsky EB, Kaul V, Paschall J, et al. An evi- dence-based approach to establish the functional and clinical significance of copy number variants in intellectual and developmental disabilities [J]. Genet Med, 2011, 13(9): 777-784.
  • 5Wapner R J, Martin CL, Levy B, et al. Chromosomal microarray versus karyotyping for prenatal diagnosis [J]. N EnglJMed, 2012, 367(23): 2175-2184.
  • 6Moeschler JB. Medical genetics diagnostic evaluation of thechild with global developmental delay or intellectual dis- ability [J]. Curr Opin Neurol, 2008, 21 (2): i 17-122.
  • 7Perou R, Bitsko RH, Blumberg SJ, et al. Mental health surveillance among children--United States, 2005-2011 [J]. MMWR Surveill Summ, 2013, 62(Suppl 2).- 1-35.
  • 8Michelson D J, Shevell MI, Sherr EH, et al. Evi- dence report: genetic and metabolic testing on chil- dren with global developmental delay: report of the Quality Standards Subcommittee of the American Acade- my of Neurology and the Practice Committee of the Child Neurology Society [J], Neurology, 2011, 77(17): 1629-1635.
  • 9Miller DT, Adam MP, Aradhya S, et al. Consensus statement: chromosomal microarray is a first-tier clinical diagnostic test for individuals with developmental disabili- ties or congenital anomalies [J]. Am J Hum Genet, 2010, 86(5)~ 749-764.
  • 10Cooper GM, Coe BP, Girirajan S, et al, A copy number variation morbidity map of developmental delay [J]. Nat Genet, 2011, 43(9).. 838-846.

共引文献220

同被引文献26

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部